Report Categories

According to our (Global Info Research) latest study, the global Age Related Macular Degeneration (AMD) market size was valued at USD 7949.4 million in 2023 and is forecast to a readjusted size of USD 11600 million by 2030 with a CAGR of 5.6% during review period.

USD3480.00

Add To Cart

According to our (Global Info Research) latest study, the global Wet Age Related Macular Degeneration (AMD) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

Add To Cart

According to our (Global Info Research) latest study, the global Age-Related Macular Degeneration (AMD) Therapeutics market size was valued at USD 7949.4 million in 2023 and is forecast to a readjusted size of USD 11600 million by 2030 with a CAGR of 5.6% during review period.

USD3480.00

Add To Cart

Age-related macular degeneration (AMD) is a progressive eye disease that affects the macula, a part of the retina responsible for central vision. The cells in the macula become damaged and begin to die, causing vision loss as a person ages. The disease is typically categorized into two types: dry age-related macular degeneration (AMD) and wet age-related macular degeneration (AMD). Dry AMD is more common and involves the formation of small, yellow deposits in the macula, while wet AMD is less common and involves the growth of abnormal blood vessels beneath the macula. In dry AMD, treatment options include vitamin supplements and lifestyle changes to reduce risk factors. In wet AMD, treatment involves medications that are injected into the eye to stop the growth of abnormal blood vessels. This treatment is called abnormal endothelial growth factor (anti-VEGF) therapy, and it works by blocking the protein that stimulates the growth of abnormal blood vessels.

USD4480.00

Add To Cart

Age-related macular degeneration (AMD) is a progressive eye disease that affects the macula, a part of the retina responsible for central vision. The cells in the macula become damaged and begin to die, causing vision loss as a person ages. The disease is typically categorized into two types: dry age-related macular degeneration (AMD) and wet age-related macular degeneration (AMD). Dry AMD is more common and involves the formation of small, yellow deposits in the macula, while wet AMD is less common and involves the growth of abnormal blood vessels beneath the macula. In dry AMD, treatment options include vitamin supplements and lifestyle changes to reduce risk factors. In wet AMD, treatment involves medications that are injected into the eye to stop the growth of abnormal blood vessels. This treatment is called abnormal endothelial growth factor (anti-VEGF) therapy, and it works by blocking the protein that stimulates the growth of abnormal blood vessels.

USD3480.00

Add To Cart

Age-related macular degeneration (AMD) represents one of leading cause of visual impairment in developed countries and a major target for AI-based approaches. The analysis of AMD data is mainly based on optical coherence tomography(OCT) images; thus, image segmentation is a fundamental step for accurately recognizing retinal structures. Many unsupervised AI-based segmentation algorithms have been developed, providing very high performance in detecting retinal features. These algorithms are useful not only for assessing the integrity of retinal structures, but also for localizing and quantifying retinal fluids during follow-up.

USD4480.00

Add To Cart

Age-related macular degeneration (AMD) represents one of leading cause of visual impairment in developed countries and a major target for AI-based approaches. The analysis of AMD data is mainly based on optical coherence tomography(OCT) images; thus, image segmentation is a fundamental step for accurately recognizing retinal structures. Many unsupervised AI-based segmentation algorithms have been developed, providing very high performance in detecting retinal features. These algorithms are useful not only for assessing the integrity of retinal structures, but also for localizing and quantifying retinal fluids during follow-up.

USD3480.00

Add To Cart

The global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

According to our (Global Info Research) latest study, the global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

Add To Cart

This report studies the global Age Related Macular Degeneration (AMD) demand, key companies, and key regions.

USD4480.00

Add To Cart